Immunocore Holdings (IMCR) Selling, General & Administrative (2021 - 2026)
Immunocore Holdings (IMCR) recorded Selling, General & Administrative of $43.89 million in Q2 2026, up 2.6% from $42.79 million a year earlier and up 16.0% from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Selling, General & Administrative (2021 - 2026) Analysis & Trends
On a TTM basis, Immunocore Holdings' Selling, General & Administrative came in at $164.16 million as of Jun 30, 2026, up 2.1% year-over-year; for FY2025, it was $165.41 million, up 6.2% from FY2024.
- Annual Selling, General & Administrative has increased for five straight years, with a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $155.78 million in FY2024 (+7.8%), $144.5 million in FY2023 (+17.4%), $123.06 million in FY2022 (+11.0%) and $110.82 million in FY2021 (+83.5%).
- The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q4 2022.
- On a year-over-year basis, Selling, General & Administrative rose in seven of the last eight quarters, with growth averaging 3.1%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 158.0% in Q3 2023, against a decline of 50.3% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $37.85 million (Q1 2026), $42.65 million (Q4 2025) and $39.78 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Immunocore Holdings | 1.53 Bn | -1.95 Bn | 114.84 Mn | 43.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.89 Mn |
| Mar 31, 2026 | 37.85 Mn |
| Dec 31, 2025 | 42.65 Mn |
| Sep 30, 2025 | 39.78 Mn |
| Jun 30, 2025 | 42.79 Mn |
| Mar 31, 2025 | 40.20 Mn |
| Dec 31, 2024 | 42.32 Mn |
| Sep 30, 2024 | 35.53 Mn |
| Jun 30, 2024 | 38.64 Mn |
| Mar 31, 2024 | 39.29 Mn |
| Dec 31, 2023 | 41.45 Mn |
| Sep 30, 2023 | 35.47 Mn |
| Jun 30, 2023 | 42.40 Mn |
| Mar 31, 2023 | 32.57 Mn |
| Dec 31, 2022 | 50.60 Mn |
| Sep 30, 2022 | 13.75 Mn |
| Jun 30, 2022 | 25.32 Mn |
| Dec 31, 2021 | 32.85 Mn |
| Sep 30, 2021 | 27.64 Mn |
API Access
Immunocore Holdings Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();